Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trialJohann S. de Bono, Ulrik Lassen, Nicole Concin et al.|The Lancet Oncology|2019Cited by 228
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancerGiorgio Bogani, Mansoor Raza Mirza, Brian M. Slomovitz et al.|Annals of Oncology|2024Cited by 123